Bar Admissions

  • Maryland
  • Pennsylvania

Court Admissions

  • U.S. District Court for the District of Maryland

Education

  • J.D., magna cum laude, Widener University School of Law, 1996
    Member of Executive Board, Widener Journal of Public Law, 1995-1996
  • B.A., Bucknell University, 1993

Judicial Clerkships

  • Honorable Marvin J. Garbis, U.S. District Court for the District of Maryland, 1996 - 1997
T +1 410.244.7704
F +1 410.244.7742
 

Sally W. Bryan

Partner

Sally Bryan is co-chair of the Product Liability and Mass Torts Practice Group. Her practice primarily consists of litigation within the pharmaceutical industry and also involves litigation of matters in other commercial settings.

In the pharmaceutical setting, for almost twenty years, Sally has been part of multiple regional and national representations involving both vaccines and drug products. She has had direct or supervisory responsibility for a wide variety of activities in this capacity, including interacting extensively with company witnesses in connection with the factual development of her clients' company cases; designing and using databases for the management, analysis and production of documents in matters of all sizes; supervising and managing the collection, review and production of both hard copy and electronic documents in matters of varying sizes; and overseeing third-party vendors and dozens of attorneys and paralegals working in various capacities. In recent years, Sally has provided similar services to clients in other commercial settings, including those who conduct medical research and those in the healthcare and defense industries.

Representative Matters

In recent years, Sally has provided the litigation-related services described above in the following settings:

Pharmaceutical
  • The representation of a vaccine manufacturer in a nationwide litigation involving the allegation that a preservative in vaccines causes autism.
  • The representation of the manufacturer of a vaccine that protects against human papillomavirus in x-US matters involving multiple claimed injuries.
  • The representation of the manufacturer of a vaccine used to prevent herpes zoster virus where plaintiff claimed that the vaccine caused a neurologic injury.
  • The representation of the manufacturer of a cholesterol-reducing drug in a nationwide litigation where plaintiffs claimed that the drug caused the development of muscle and psychological injuries.
  • The representation of the manufacturer of an antiepileptic drug in a nationwide litigation involving allegations of birth defect injuries.
  • The representation of the manufacturer of a pain medication in a nationwide litigation involving allegations that the drug caused the development of chondrolysis.
  • The representation of the manufacturer in a nationwide litigation where plaintiffs claimed that an injectable drug used to control nausea and vomiting led to the development of tardive dyskinesia.

Commercial
  • The representation of a prominent medical research institution and researcher in a case involving a claim of research fraud.
  • The representation of an information security company in a case involving a dispute over the use of encryption technology.
  • The representation of a regional healthcare system in a case involving a breach-of-contract claim related to the supply of drugs to hospitals.
  • The representation of a leading advanced materials company in connection with its use of cadmium in enamels.

Investigations
  • The representation of a vaccine manufacturer in connection with a government investigation regarding a claim of research fraud.
  • The representation of a pharmaceutical manufacturer in connection with an internal investigation regarding a scientist’s purported misconduct.
  • The representation of a pharmaceutical/vaccine manufacturer in connection with several congressional inquiries.